Boston Scientific Corporation (0HOY.L)
USD 89.2
(-1.53%)
USD 89.2
(-1.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.23 Billion USD | 6.07% |
| 2022 | 8.2 Billion USD | 10.7% |
| 2021 | 7.41 Billion USD | -3.39% |
| 2020 | 7.67 Billion USD | -21.62% |
| 2019 | 9.78 Billion USD | 56.48% |
| 2018 | 6.25 Billion USD | 35.24% |
| 2017 | 4.62 Billion USD | -8.33% |
| 2016 | 5.04 Billion USD | -5.84% |
| 2015 | 5.35 Billion USD | 46.51% |
| 2014 | 3.65 Billion USD | -9.28% |
| 2013 | 4.03 Billion USD | 2047.34% |
| 2012 | -207 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 8.57 Billion USD | 0.97% |
| 2024 Q2 | 7.65 Billion USD | -10.78% |
| 2024 Q3 | 8.3 Billion USD | 8.56% |
| 2023 FY | 8.49 Billion USD | 3.56% |
| 2023 Q4 | 8.49 Billion USD | 3.32% |
| 2023 Q2 | 8.89 Billion USD | 2.69% |
| 2023 Q3 | 8.22 Billion USD | -7.52% |
| 2023 Q1 | 8.66 Billion USD | 5.55% |
| 2022 Q4 | 8.2 Billion USD | -3.29% |
| 2022 Q2 | 8.92 Billion USD | -3.16% |
| 2022 Q1 | 9.21 Billion USD | 24.28% |
| 2022 FY | 8.2 Billion USD | 10.7% |
| 2022 Q3 | 8.48 Billion USD | -4.9% |
| 2021 Q2 | 6.62 Billion USD | -10.84% |
| 2021 Q4 | 7.41 Billion USD | 0.71% |
| 2021 FY | 7.41 Billion USD | -3.39% |
| 2021 Q3 | 7.36 Billion USD | 11.08% |
| 2021 Q1 | 7.43 Billion USD | -4.84% |
| 2020 FY | 7.67 Billion USD | -21.62% |
| 2020 Q1 | 10.23 Billion USD | 1.66% |
| 2020 Q2 | 8.07 Billion USD | -21.14% |
| 2020 Q4 | 7.81 Billion USD | 3.17% |
| 2020 Q3 | 7.57 Billion USD | -6.21% |
| 2019 Q3 | 10.86 Billion USD | 12.88% |
| 2019 Q2 | 9.62 Billion USD | 3.46% |
| 2019 FY | 9.78 Billion USD | 56.48% |
| 2019 Q1 | 9.3 Billion USD | 33.74% |
| 2019 Q4 | 10.06 Billion USD | -7.31% |
| 2018 Q2 | 6.28 Billion USD | 14.73% |
| 2018 Q1 | 5.47 Billion USD | 0.92% |
| 2018 FY | 6.25 Billion USD | 35.24% |
| 2018 Q4 | 6.95 Billion USD | 7.68% |
| 2018 Q3 | 6.45 Billion USD | 2.75% |
| 2017 Q4 | 5.42 Billion USD | -0.8% |
| 2017 FY | 4.62 Billion USD | -8.33% |
| 2017 Q2 | 5.64 Billion USD | 5.26% |
| 2017 Q1 | 5.35 Billion USD | 1.32% |
| 2017 Q3 | 5.47 Billion USD | -2.98% |
| 2016 Q1 | 5.33 Billion USD | -0.35% |
| 2016 Q4 | 5.28 Billion USD | 1.93% |
| 2016 Q3 | 5.18 Billion USD | 3.99% |
| 2016 Q2 | 4.98 Billion USD | -6.56% |
| 2016 FY | 5.04 Billion USD | -5.84% |
| 2015 Q2 | 4.2 Billion USD | 4.55% |
| 2015 FY | 5.35 Billion USD | 46.51% |
| 2015 Q4 | 5.35 Billion USD | -2.74% |
| 2015 Q3 | 5.5 Billion USD | 30.89% |
| 2015 Q1 | 4.02 Billion USD | 10.09% |
| 2014 Q2 | 3.89 Billion USD | -3.94% |
| 2014 Q3 | 4 Billion USD | 2.77% |
| 2014 Q4 | 3.65 Billion USD | -8.71% |
| 2014 FY | 3.65 Billion USD | -9.28% |
| 2014 Q1 | 4.05 Billion USD | 0.67% |
| 2013 Q2 | 3.72 Billion USD | -6.62% |
| 2013 Q1 | 3.98 Billion USD | 2025.6% |
| 2013 FY | 4.03 Billion USD | 2047.34% |
| 2013 Q3 | 3.67 Billion USD | -1.18% |
| 2013 Q4 | 4.03 Billion USD | 9.6% |
| 2012 Q4 | -207 Million USD | 0.0% |
| 2012 FY | -207 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 10997.971% |
| Accuray Incorporated | 103.58 Million USD | -7847.02% |
| Align Technology, Inc. | -840.47 Million USD | 1079.452% |
| Elevance Health Inc. | 18.59 Billion USD | 55.728% |
| AxoGen, Inc. | 32.26 Million USD | -25412.924% |
| CVS Health Corporation | 71.18 Billion USD | 88.436% |
| Cardinal Health, Inc. | 476 Million USD | -1629.412% |
| Centene Corporation | 506 Million USD | -1526.877% |
| DaVita Inc. | 10.65 Billion USD | 22.717% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 79.885% |
| Hologic, Inc. | 374.4 Million USD | -2098.718% |
| Humana Inc. | 5.51 Billion USD | -49.157% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -1566.572% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -51.955% |
| Masimo Corporation | 804 Million USD | -923.881% |
| McKesson Corporation | 889 Million USD | -825.984% |
| Patterson Companies, Inc. | 648.47 Million USD | -1169.434% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -75.785% |
| ResMed Inc. | 635.57 Million USD | -1195.207% |
| Henry Schein, Inc. | 2.57 Billion USD | -220.311% |
| Teladoc Health, Inc. | 468.6 Million USD | -1656.715% |
| Universal Health Services, Inc. | 5.24 Billion USD | -56.884% |
| Veeva Systems Inc. | -647.71 Million USD | 1370.935% |
| Baxter International Inc. | 11.16 Billion USD | 26.276% |
| Becton, Dickinson and Company | 14.46 Billion USD | 43.082% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 409.439% |
| Danaher Corporation | 13.49 Billion USD | 38.986% |
| Stryker Corporation | 10.02 Billion USD | 17.877% |
| Medtronic plc | 23.67 Billion USD | 65.235% |